Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C

  1. Eric J. Arts1,2,3,*
  1. 1Division of Infectious Diseases, Department of Medicine
  2. 2Molecular Virology Program
  3. 3Department of Pharmacology
  4. 5Division of Geographical Medicine, Department of Medicine, Case Western Reserve University
  5. 4Department of Virology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  6. 6Dermatology Branch, National Cancer Institute, Bethesda, Maryland

ABSTRACT

Continual human immunodeficiency virus type 1 (HIV-1) evolution and expansion within the human population have led to unequal distribution of HIV-1 group M subtypes. In particular, recent outgrowth of subtype C in southern Africa, India, and China has fueled speculation that subtype C isolates may be more fit in vivo. In this study, nine subtype B and six subtype C HIV-1 isolates were added to peripheral blood mononuclear cell cultures for a complete pairwise competition experiment. All subtype C HIV-1 isolates were less fit than subtype B isolates (P < 0.0001), but intrasubtype variations in HIV-1 fitness were not significant. Increased fitness of subtype B over subtype C was also observed in primary CD4+ T cells and macrophages from different human donors but not in skin-derived human Langerhans cells. Detailed analysis of the retroviral life cycle during several B and C virus competitions indicated that the efficiency of host cell entry may have a significant impact on relative fitness. Furthermore, phyletic analyses of fitness differences suggested that, for a recombined subtype B/C HIV-1 isolate, higher fitness mapped to the subtype B env gene rather than the subtype C gag and pol genes. These results suggest that subtype B and C HIV-1 may be transmitted with equal efficiency (Langerhans cell data) but that subtype C isolates may be less fit following initial infection (T-cell and macrophage data) and may lead to slower disease progression.

FOOTNOTES

    • Received 30 July 2002.
    • Accepted 22 October 2002.
  • *Corresponding author. Mailing address: Division of Infectious Diseases, BRB 1029, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Phone: (216) 368-8904. Fax (216)-368 2034. E-mail: eja3{at}po.cwru.edu.
| Table of Contents